Delivery Order HSHQDC10D00025-HSHQDC10J00339

Glaxosmithkline, LLC has been awarded a $52,500 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical blanket purchase agreement to provide 8509429659 Zanamivir for Inhal to the Research Triangle Park, NC location. The contract has no set-aside designation and deliveries must be completed by April 17, 2023. Zanamivir is an antiviral medication used to treat and prevent influenza. This delivery order will support the Agency's stockpiling efforts to ensure...

Glaxosmithkline, LLC was awarded a $23,625 firm fixed price delivery order against an unidentified contract vehicle to provide 8509429655, which is understood to be Zanamivir for inhalation, to the Defense Logistics Agency Troop Support Medical. Performance will occur in Research Triangle Park, North Carolina, with an expected completion date of April 17, 2023. No set-aside designation was applied to this award to supply the influenza antiviral medication to the agency, which supports the...

<p>Glaxosmithkline, LLC was awarded a $26,250 firm fixed price delivery order against an unidentified contracting vehicle to provide Zanamivir for inhalation to the Defense Logistics Agency Troop Support Medical. Performance will occur in Research Triangle Park, North Carolina by April 2023. No set-aside provisions were applied to this contract for the respiratory drug, which will support the agency's medical supply operations.</p>

<p>Glaxosmithkline, LLC was awarded a $24,543.75 firm fixed price delivery order against an unidentified contract vehicle to provide Zanamivir for inhalation to the Defense Logistics Agency Troop Support Medical. Performance will occur in Research Triangle Park, North Carolina by April 2023. No set-aside provisions were applied to this award to supply the inhaled antiviral medication to the agency.</p>

The U.S. government agency Medical Supply Chain awarded a firm fixed price delivery order contract worth $229,284.00 to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of zanamivir, an antiviral medication, with a period of performance ending on December 14, 2016. This contract was not set aside for any specific business type. Glaxosmithkline has previously been awarded other federal contracts and grants for the supply of various pharmaceutical products and services,...

This is a federal delivery order contract awarded by the Defense agency Medical Supply Chain to the prime contractor Glaxosmithkline, LLC for the supply of the antiviral medication zanamivir for inhalation. The contract has a ceiling value of $325,166.40 and was awarded on a firm fixed price basis with no set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and grants, including influenza...

This is a $135,219.20 firm fixed price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to GlaxoSmithKline, LLC for the supply of the antiviral medication zanamivir. The contract has a completion date of February 19, 2019 and was awarded on September 20, 2018. There was no set-aside designation used. GlaxoSmithKline, a foreign-owned pharmaceutical company, has provided a range of pharmaceutical goods and services to U.S. government agencies through federal...

Glaxosmithkline, LLC was awarded a $10,500 firm fixed price delivery order against an unidentified contract vehicle to provide Zanamivir for inhalation to the Defense Logistics Agency Troop Support Medical. The delivery order has a period of performance through April 2023 and was awarded without a set-aside designation in September 2022. The place of performance is Research Triangle Park, North Carolina, where the prime contractor Glaxosmithkline is headquartered. No major subcontractors were...

This is a firm fixed-price delivery order awarded by the U.S. Department of Homeland Security, Countering Weapons of Mass Destruction office, to GlaxoSmithKline, LLC for the purchase of 30,800 courses of the antiviral medication Relenza at $21.72 per course, with a total ceiling value of $668,976. The order supports the Medical Countermeasures Program within the Occupational Health Branch. There was no set-aside designation for this award. GlaxoSmithKline is a pharmaceutical company that has...

<p>Glaxosmithkline, LLC was awarded a $26,250 firm fixed price delivery order against an unidentified contracting vehicle to provide 8509429716, zanamivir for inhalation, to the Defense Logistics Agency Troop Support Medical. Performance will occur in Research Triangle Park, North Carolina by April 17, 2023. No set-aside provisions were applied to this award to supply the influenza antiviral medication to the agency, which supports the medical needs of the Department of Defense.</p>